Clinical Trials Logo

Eculizumab clinical trials

View clinical trials related to Eculizumab.

Filter by:
  • None
  • Page 1

NCT ID: NCT04725812 Terminated - Pregnancy Related Clinical Trials

Complement Regulation to Undo Systemic Harm in Preeclampsia

CRUSH
Start date: September 13, 2021
Phase: Phase 2
Study type: Interventional

This is a Phase II, single arm, open-label study to determine if treatment with eculizumab prolongs pregnancy compared to historical controls in women with preeclampsia between 23-30 weeks gestation.

NCT ID: NCT04079257 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria

PREPARE
Start date: February 23, 2021
Phase:
Study type: Observational

Because of the inter and intra individual variability in pharmacokinetics and pharmacodynamics of eculizumab in PNH patients, a tailored treatment approach for the individual is probably preferable. The starting point of a robust tailored dosing approach for eculizumab is the development of a population pharmacokinetic-pharmacodynamic model. In this cross-sectional observational pharmacokinetic and pharmacodynamic study, trough and peak concentrations of eculizumab are measured to describe the pharmacokinetics and complement activation markers to describe the pharmacodynamics.